Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 55 of the 57 references it cites were found in a registry or an index.

A Placebo-Controlled Study of Lamotrigine and Gabapentin Monotherapy in Refractory Mood Disorders

Abstract

There is a pressing need for additional treatment options for refractory mood disorders. This controlled comparative study evaluated the efficacy of lamotrigine (LTG) and gabapentin (GBP) monotherapy versus placebo (PLC). Thirty-one patients with refractory bipolar and unipolar mood disorders participated in a double-blind, randomized, crossover series of three 6-week monotherapy evaluations including LTG, GBP, and PLC. There was a standardized blinded titration to assess clinical efficacy or to determine the maximum tolerated daily dose (LTG 500 mg or GBP 4,800 mg). The primary outcome measure was the Clinical Global Impressions Scale (CGI) for Bipolar Illness as supplemented by other standard rating instruments. The mean doses at week 6 were 274 +/- 128 mg for LTG and 3,987 +/- 856 mg for GBP. Response rates (CGI ratings of much or very much improved) were the following: LTG, 52% (16/31); GBP, 26% (8/31); and PLC, 23% (7/31) (Cochran's Q = 6.952, df = 2, N = 31, p = 0.031). Post hoc Q differences (df = 1, N = 31) were the following: LTG versus GBP (Qdiff = 5.33, p = 0.011); LTG versus PLC (Qdiff = 4.76, p = 0.022); and GBP versus PLC (Qdiff = 0.08, p = 0.70). With respect to anticonvulsant dose and gender, there was no difference between the responders and the nonresponders. The agents were generally well tolerated. This controlled investigation preliminarily suggests the efficacy of LTG in treatment-refractory affectively ill patients. Further definition of responsive subtypes and the role of these medications in the treatment of mood disorders requires additional study.

Overview

Integrity signals

Registry

Crossref · 10.1097/00004714-200012000-00004

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 57 references

Research works printed but not linked: 11

  1. Bowden, 1994, JAMA, 271, 918, 10.1001/jama.271.12.918 · doi:10.1001/jama.271.12.918 · Paper page
  2. Himmelhoch, 1986, Psychopharmacol Bull, 22, 613
  3. Otsuki, 1995, Jpn J Neuropsychopharmacol, 17, 35
  4. Calabrese, 1996, Am J Psychiatry, 153, 1236
  5. Labbate, 1997, Am J Psychiatry, 154, 1317
  6. Kusumakar, 1997, Am J Psychiatry, 154, 1171
  7. Stanton, 1997, Am J Psychiatry, 154, 287
  8. Leverich, 1996, Curr Rev Mood Anxiety Disord, 1, 48
  9. Overall, 1962, Psychol Rep, 10, 799, 10.2466/PR0.10.3.799-812 · doi:10.2466/pr0.10.3.799-812 · Paper page
  10. Kraemer, 1991, Psychopharmacol Bull, 3, 217
  11. Cora-Locatelli, 1998, J Clin Psychiatry, 59, 400

Cited by

See all 448

Metadata

Authors
Frye, M. A., Ketter, T. A., Kimbrell, T. A., Dunn, R. T., Speer, A. M., Osuch, E. A., Luckenbaugh, D. A., Corá-Locatelli, G., Leverich, G. S., & Post, R. M.
Affiliations
  • National Institutes of Health (US)
  • Stanford Medicine (US)
Corresponding author
  • Frye, Mark A.
  • Kimbrell, Timothy A.
  • Dunn, Robert T.
  • Speer, Andrew M.
  • Osuch, Elizabeth A.
  • Luckenbaugh, David A.
  • Leverich, Gabriele S.
  • Post, Robert M.
Venue
Journal of Clinical Psychopharmacology
Published
2000-12
Volume
20
Issue
6
Pages
607-614
ISSN
0271-0749 (ISSN-L)
OpenAlex
W2037231243
Cited by
446
References
57
Citations by year
2025: 3 · 2024: 6 · 2022: 5 · 2021: 7 · 2020: 5 · 2019: 8 · 2018: 4 · 2017: 8 · 2016: 15 · 2015: 7 · 2014: 5 · 2013: 6 · 2012: 20
FWCI
29.72
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
lamotrigine, gabapentin, bipolar disorder, major depressive disorder, anticonvulsant monotherapy, Clinical Global Impression Scale, drug efficacy, tolerability, dose titration
MeSH terms
Gabapentin, Lamotrigine, Acetates, Adult, Amines, Cyclohexanecarboxylic Acids, Double-Blind Method, Female, gamma-Aminobutyric Acid, Humans, Male, Middle Aged, Placebos, Psychiatric Status Rating Scales, Triazines, Treatment Outcome, Cross-Over Studies, Antimanic Agents, Mood Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Placebo-Controlled Study of Lamotrigine and Gabapentin Monotherapy in Refractory Mood Disorders. https://app.cochat.ai/papers/10.1097/00004714-200012000-00004
The paper
Frye, M. A., Ketter, T. A., Kimbrell, T. A., Dunn, R. T., Speer, A. M., Osuch, E. A., Luckenbaugh, D. A., Corá-Locatelli, G., Leverich, G. S., & Post, R. M. (2000). A Placebo-Controlled Study of Lamotrigine and Gabapentin Monotherapy in Refractory Mood Disorders. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/00004714-200012000-00004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.